Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Nicholas James, MBBS, PhD, FRCP, FRCR, The Institute of Cancer Research, London, UK, shares his highlights from a session on practising beyond clinical trial data in urothelial cancer. Specifically, he discusses adjuvant chemotherapy and immuno-oncology. This interview was recorded at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.